ScoreWhy is Guizhou Bailing Group Pharmaceutical Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 2.43%
- The company has been able to generate a Return on Capital Employed (avg) of 2.43% signifying low profitability per unit of total capital (equity and debt)
2
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 2.50% and Operating profit at -145.85% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 1.63% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 2.50% and Operating profit at -145.85% over the last 5 years
4
The company has declared Negative results for the last 6 consecutive quarters
- NET SALES(Q) At CNY 751.32 MM has Fallen at -42.92%
- NET PROFIT(Q) At CNY 24.17 MM has Fallen at -53.25%
- PRE-TAX PROFIT(Q) At CNY 36.66 MM has Fallen at -43.31%
5
With ROE of 0.17%, it has a risky valuation with a 1.81 Price to Book Value
- Over the past year, while the stock has generated a return of 42.72%, its profits have risen by 101.2% ; the PEG ratio of the company is 10.8
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Guizhou Bailing Group Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Guizhou Bailing Group Pharmaceutical Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Guizhou Bailing Group Pharmaceutical Co., Ltd.
29.21%
1.62
37.56%
China Shanghai Composite
14.77%
1.01
15.10%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
2.50%
EBIT Growth (5y)
-145.85%
EBIT to Interest (avg)
0.17
Debt to EBITDA (avg)
7.58
Net Debt to Equity (avg)
0.43
Sales to Capital Employed (avg)
0.73
Tax Ratio
50.71%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.43%
ROE (avg)
1.63%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
1093
Industry P/E
Price to Book Value
1.81
EV to EBIT
-1151.02
EV to EBITDA
63.59
EV to Capital Employed
1.58
EV to Sales
2.33
PEG Ratio
10.81
Dividend Yield
NA
ROCE (Latest)
-0.14%
ROE (Latest)
0.17%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
NET PROFIT(HY)
Higher at CNY -30.04 MM
-19What is not working for the Company
NET SALES(Q)
At CNY 751.32 MM has Fallen at -42.92%
NET PROFIT(Q)
At CNY 24.17 MM has Fallen at -53.25%
PRE-TAX PROFIT(Q)
At CNY 36.66 MM has Fallen at -43.31%
RAW MATERIAL COST(Y)
Grown by 19.57% (YoY
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.34%
DEBTORS TURNOVER RATIO(HY)
Lowest at 1.32%
Here's what is not working for Guizhou Bailing Group Pharmaceutical Co., Ltd.
Net Sales
At CNY 751.32 MM has Fallen at -42.92%
Year on Year (YoY)MOJO Watch
Near term sales trend is extremely negative
Net Sales (CNY MM)
Net Profit
At CNY 24.17 MM has Fallen at -53.25%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Pre-Tax Profit
At CNY 36.66 MM has Fallen at -43.31%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Inventory Turnover Ratio
Lowest at 1.34%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 1.32%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 19.57% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
